Written by 
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year. Revenue rose 7% YoY to Rs 3,434 crore in Q2FY25. EBITDA grew 30.2% YoY to Rs 602 crore, […]
